Funder: National Institutes of Health
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $5,000,000; approximately 5 awards expected; R01 mechanism.
Summary: Supports research to address methodological challenges in clinical trials of rapid-acting psychotropic interventional drugs for mental health disorders.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.